Atrial Fibrillation Linked to Depression

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
According to a German study published in PLOS ONE, atrial fibrillation may increase the risk for depression. A large sample of adults were assessed for depression on a scale using the Patient Health Questionnaire. On average, patients with atrial fibrillation scored a point higher on the scale of depression than those without atrial fibrillation. However, these scores were not severe enough to indicate the need for treatment. The study also found that atrial fibrillation patients living without a current partnership had a more prominent history of depression and self-rated their mental health status lower than those without the condition.

To read the full article on HCPLive.com, click here.
Related Articles
One of the most common questions from prescribers that I have answered in the past year concerns how to convert from 1 anticoagulant to anothe
Preliminary results of an ongoing post-marketing study examining Janssen Pharmaceuticals’ rivaroxaban (Xarelto) in patients with non-valvular atrial fibrillation (NVAF) indicate that the anti-clotting drug’s safety in real-world settings is consistent with the findings of previous phase 3 clinical trials.
Depression and other behavior changes may show up in people who will later develop Alzheimer’s disease even before they start having memory problems.
The FDA has approved Daiichi Sankyo’s anti-clotting drug, edoxaban (Savaysa), as a once-daily treatment to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$